Cargando…
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors
Receptor-Interacting serine/threonine-Protein Kinase 1 (RIPK1) emerged as an important driver of inflammation and, consequently, inflammatory pathologies. The enzymatic activity of RIPK1 is known to indirectly promote inflammation by triggering cell death, in the form of apoptosis, necroptosis and p...
Autores principales: | Scarpellini, Camilla, Valembois, Sophie, Goossens, Kenneth, Vadi, Mike, Lanthier, Caroline, Klejborowska, Greta, Van Der Veken, Pieter, De Winter, Hans, Bertrand, Mathieu J. M., Augustyns, Koen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119423/ https://www.ncbi.nlm.nih.gov/pubmed/37090247 http://dx.doi.org/10.3389/fchem.2023.1160164 |
Ejemplares similares
-
The Potential Role of Regulated Cell Death in Dry Eye Diseases and Ocular Surface Dysfunction
por: Scarpellini, Camilla, et al.
Publicado: (2023) -
PERK‐STING‐RIPK3 pathway facilitates cognitive impairment by inducing neuronal necroptosis in sepsis‐associated encephalopathy
por: Xiaofeng, Guo, et al.
Publicado: (2023) -
Necroptosis: Fifty shades of RIPKs
por: Ichim, Gabriel, et al.
Publicado: (2014) -
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
por: Xia, Kaijiang, et al.
Publicado: (2020) -
Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis
por: Remijsen, Q, et al.
Publicado: (2014)